Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide COOL-AF Registry

Background: Warfarin remains the most commonly used oral anticoagulant (OAC) in Thailand for stroke prevention among patients with non-valvular atrial fibrillation (NVAF). The aim of this study was to investigate the relationship between time in therapeutic range (TTR) after warfarin initiation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Krittayaphong, Rungroj, Chantrarat, Thoranis, Rojjarekampai, Roj, Jittham, Pongpun, Sairat, Poom, Lip, Gregory Y.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355466/
https://www.ncbi.nlm.nih.gov/pubmed/32498302
http://dx.doi.org/10.3390/jcm9061698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355466/
https://www.ncbi.nlm.nih.gov/pubmed/32498302
http://dx.doi.org/10.3390/jcm9061698

Ejemplares similares